mTOR signaling in stem and progenitor cells
Development2018Vol. 145(1)
Citations Over TimeTop 10% of 2018 papers
Abstract
The mammalian target of rapamycin (mTOR) senses nutrients and growth factors to coordinate cell growth, metabolism and autophagy. Extensive research has mapped the signaling pathways regulated by mTOR that are involved in human diseases, such as cancer, and in diabetes and ageing. Recently, however, new studies have demonstrated important roles for mTOR in promoting the differentiation of adult stem cells, driving the growth and proliferation of stem and progenitor cells, and dictating the differentiation program of multipotent stem cell populations. Here, we review these advances, providing an overview of mTOR signaling and its role in murine and human stem and progenitor cells.
Related Papers
- → Targeting mTOR globally in cancer: Thinking beyond rapamycin(2009)155 cited
- → Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets(2024)16 cited
- → Evaluating the mTOR Pathway in Physiological and Pharmacological Settings(2016)7 cited
- → AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1(2022)6 cited
- → mTOR signaling in liver disease(2015)2 cited